1.
J Am Coll Emerg Physicians Open
; 5(4): e13252, 2024 Aug.
Article
in English
| MEDLINE
| ID: mdl-39131824
2.
Open Forum Infect Dis
; 6(1): ofy351, 2019 Jan.
Article
in English
| MEDLINE
| ID: mdl-30631796
ABSTRACT
In the Consortium on Resistance Against Carbapenems in Klebsiella and other Enterobacteriaceae (CRACKLE), trimethoprim-sulfamethoxazole (TMP-SMX) had a limited role in the treatment of less severe carbapenem-resistant Enterobacteriaceae (CRE) infections, especially urinary tract infections. Of tested CRE, only 29% were susceptible to TMP-SMX. Development of resistance further limits the use of TMP-SMX in CRE infections.